
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Korro Bio, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are desi... Korro Bio, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Its Oligonucleotide Promoted Editing of RNA (OPERA) is a foundational platform for RNA editing, which is designed to edit RNA in vivo by delivering an oligonucleotide guide that can target specific RNA sequences. The Company's first development candidate, KRRO-110, is in development as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD), that has the potential to be disease-modifying and provide a differentiated therapeutic option. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.07 | -12.0866141732 | 25.4 | 25.63 | 20.34 | 76398 | 23.20368983 | CS |
4 | -13.97 | -38.4848484848 | 36.3 | 36.3 | 20.34 | 65709 | 27.0161432 | CS |
12 | -21.64 | -49.2153741187 | 43.97 | 52 | 20.34 | 78755 | 36.06313965 | CS |
26 | -18.06 | -44.7140381282 | 40.39 | 98 | 20.34 | 107030 | 50.38410014 | CS |
52 | -27.75 | -55.411341853 | 50.08 | 98 | 20.34 | 84826 | 49.18938716 | CS |
156 | 9.33 | 71.7692307692 | 13 | 98 | 13 | 74728 | 48.81851873 | CS |
260 | 9.33 | 71.7692307692 | 13 | 98 | 13 | 74728 | 48.81851873 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions